Periodontal Diseases
1
Pipeline Programs
3
Companies
4
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
3 companies ranked by most advanced pipeline stage
Geistlich PharmaSwitzerland - Root
2 programsConnective Tissue Graft TechniqueN/A1 trial
Periodontal Access FlapN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Jerusalem PharmaceuticalsPeriActive
Geistlich PharmaPeriodontal Access Flap
BiolaseMIST
Geistlich PharmaConnective Tissue Graft Technique
Clinical Trials (4)
Total enrollment: 111 patients across 4 trials
Evaluation and Comparison of Efficacy of PeriActive Mouthwash to Chlorhexidine 0.12% Mouth Rinse
Start: Dec 2018Est. completion: Feb 202044 patients
Phase 4Unknown
Hyaluronic Acid and Polynucleotides for Supra-bony Defects
Start: Oct 2024Est. completion: Dec 202624 patients
N/ARecruiting
Controlled Study Comparing REPaiR® and MIST Therapies for Treatment of Periodontitis
Start: May 2018Est. completion: May 2020
N/ACompleted
Pinhole Surgical Technique Compared to Connective Tissue Graft in Treatment of Gingival Recession
Start: Jan 2018Est. completion: Apr 202343 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 111 patients
3 companies competing in this space